Skip to search formSkip to main contentSkip to account menu

Praxilene

Known as: Praxilène, Merck Lipha Santé Brand 1 of Naftidrofuryl Oxalate, Faes Brand of Naftidrofuryl Oxalate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
PURPOSE: To evaluate the effects of an S2 specific antiserotonine agent (Naftidrofuryl) on the optic nerve head blood flow in… 
Review
1992
Review
1992
When the prevention of coronary artery disease (CAD) is discussed, two questions invariably arise concerning alcohol. Does… 
1990
1990
Osteonecrosis of the femoral head (ONFH) is considered to be of ischemic origin, i.e. due to a decrease in blood supply within… 
1986
1986
In experimental and clinical investigations, 2-(diethylamino)ethyl-tetrahydro-alpha-(1-naphthyl-methyl)-2-furanpro pionate… 
1981
1981
A preliminary study suggested that some patients with ischaemic rest pain improved during treatment with naftidrofuryl (Praxilene… 
1980
1980
Blood flow was measured in patients with Raynaud's phenomenon, systemic sclerosis and in normal controls by venous occlusion… 
1978
1978
A method for the determination of drug efficacy in geriatric psychopharmacology is presented. Sixty patients with mild senile… 
1978
1978
Naftidrofuryl oxalate (Praxilene), defined as a vasoactivator by Becker1 has been claimed to improve the circulation… 
Review
1977
Review
1977
we suggest that patients on this drug should be carefully assessed regularly so that lesser degrees of muscle weakness are not… 
1974
1974
Naftidrofuryl (Praxilene) has been shown experimentally to improve the metabolism of brain cells where this has been impaired by…